Monoclonal-antibody-based enzyme-linked immunosorbent assay for Trichomonas vaginalis. 1988

P J Lisi, and R S Dondero, and D Kwiatkoski, and M R Spence, and M F Rein, and J F Alderete
Cistron Biotechnology, Pine Brook, New Jersey 07058.

Trichomonas vaginalis is estimated to infect 4 million women per year in the United States. The diagnosis of trichomoniasis is predominantly achieved by direct microscopic examination of vaginal exudates. This subjective diagnostic procedure is reported to be 75% sensitive under ideal circumstances. We have developed an enzyme-linked immunosorbent assay (ELISA) for the detection of T. vaginalis directly from vaginal exudates. The ELISA employs a monoclonal antibody specific for a 65-kilodalton surface polypeptide of T. vaginalis as the capture antibody in a sandwich format. A polyclonal rabbit anti-T. vaginalis antibody labeled with horseradish peroxidase serves as the probe. An evaluation of vaginal specimens from women attending clinics revealed a sensitivity and specificity of the ELISA of 89 and 97%, respectively, versus the culture technique. These results indicate the usefulness of this ELISA as an alternative to microscopic and culture methods for the detection of T. vaginalis in vaginal exudates.

UI MeSH Term Description Entries
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000913 Antibodies, Protozoan Immunoglobulins produced in a response to PROTOZOAN ANTIGENS. Protozoan Antibodies
D000953 Antigens, Protozoan Any part or derivative of any protozoan that elicits immunity; malaria (Plasmodium) and trypanosome antigens are presently the most frequently encountered. Protozoan Antigens
D014246 Trichomonas vaginalis A species of TRICHOMONAS that produces a refractory vaginal discharge in females, as well as bladder and urethral infections in males. Trichomonas vaginali,vaginali, Trichomonas
D014247 Trichomonas Vaginitis Inflammation of the vagina, marked by a purulent discharge. This disease is caused by the protozoan TRICHOMONAS VAGINALIS. Trichomoniasis, Human,Human Trichomoniases,Human Trichomoniasis,Trichomonas Vaginitides,Trichomoniases, Human,Vaginitides, Trichomonas,Vaginitis, Trichomonas

Related Publications

P J Lisi, and R S Dondero, and D Kwiatkoski, and M R Spence, and M F Rein, and J F Alderete
September 2020, Food chemistry,
P J Lisi, and R S Dondero, and D Kwiatkoski, and M R Spence, and M F Rein, and J F Alderete
July 1991, British poultry science,
P J Lisi, and R S Dondero, and D Kwiatkoski, and M R Spence, and M F Rein, and J F Alderete
September 2018, Planta medica,
P J Lisi, and R S Dondero, and D Kwiatkoski, and M R Spence, and M F Rein, and J F Alderete
March 2019, Vaccine,
P J Lisi, and R S Dondero, and D Kwiatkoski, and M R Spence, and M F Rein, and J F Alderete
February 1990, Clinical chemistry,
P J Lisi, and R S Dondero, and D Kwiatkoski, and M R Spence, and M F Rein, and J F Alderete
February 2019, Scientific reports,
P J Lisi, and R S Dondero, and D Kwiatkoski, and M R Spence, and M F Rein, and J F Alderete
November 1999, Journal of immunoassay,
P J Lisi, and R S Dondero, and D Kwiatkoski, and M R Spence, and M F Rein, and J F Alderete
January 2010, Bioorganicheskaia khimiia,
P J Lisi, and R S Dondero, and D Kwiatkoski, and M R Spence, and M F Rein, and J F Alderete
April 2013, Monoclonal antibodies in immunodiagnosis and immunotherapy,
P J Lisi, and R S Dondero, and D Kwiatkoski, and M R Spence, and M F Rein, and J F Alderete
September 1986, American journal of clinical pathology,
Copied contents to your clipboard!